aem-28
Peptideexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02100839)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314976 ↗
Also known as
- aem-28
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02100839 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2014 | Linear Clinical Research, LipimetiX Development, LLC |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Linear Clinical Research | For profit | 1 | 0 | 1 | 2014 |
| LipimetiX Development, LLC | For profit | 1 | 1 | 1 | 2014 |
2 organizations
Page 1 / 1